TMCI:NASDAQ
Treace Medical Concepts, Inc
4,81 US$
arrow_downward
-1,43%(-0,070) 1D
4,81 US$
0,00% (0,00)
bedtimeJashtë orarit
Mbyllur: 4 sht, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TMCI...
Hap
4,82 US$
I lartë
4,89 US$
I ulët
4,72 US$
Kapitalizimi i tregut
312,82 mln
Vëllimi mesatar
374,68 mijë
Vëllimi
231,83 mijë
Maksimumi 52-javor
7,63 US$
Minimumi 52-javor
1,17 US$
Fitimet për aksion
-0,93 US$
Beta
1,41
Aksionet në qarkullim
65,04 mln
Numri i punonjësve
450
Hap
4,82 US$
I lartë
4,89 US$
I ulët
4,72 US$
Kapitalizimi i tregut
312,82 mln
Vëllimi mesatar
374,68 mijë
Vëllimi
231,83 mijë
Maksimumi 52-javor
7,63 US$
Minimumi 52-javor
1,17 US$
Fitimet për aksion
-0,93 US$
Beta
1,41
Aksionet në qarkullim
65,04 mln
Numri i punonjësve
450
Profili
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Rreth Treace Medical Concepts, Inc